drug-lead-analysis

To analyze drug-likeness and ADMET properties, provide a molecule name, SMILES string, or SDF file to compute metrics like QED, SA, LogP, and Lipinski violations. The analysis generates a structured report assessing the molecule's drug candidate potential and safety profile.

Yes, you can predict BBB penetration and potential side effects by inputting a SMILES string. The analysis evaluates the molecular structure to forecast blood-brain barrier permeability and adverse effect probabilities, contributing to a comprehensive safety assessment.

A drug-lead analysis report includes QED, SA, LogP, and Lipinski violation scores for drug-likeness, alongside BBB penetration and side-effect predictions for ADMET properties. Optional visualizations are also produced to support decision-making for the drug candidate.

Evaluating lead potential involves computing multi-parameter drug-likeness and ADMET analyses for your compounds. By supplying an SDF file, you can assess multiple molecules against Lipinski rules and safety models to identify the most viable drug candidates.

No, you do not need an SDF file; you can compute Lipinski violations and QED scores by providing a molecule name or SMILES string. An SDF file is only necessary when analyzing multiple compounds or specific structural formats.

Yes, drug-likeness analysis includes optional visualization utilities to represent ADMET results and drug-likeness metrics. These visualizations help interpret the multi-parameter data and support structural decision-making for the molecule.